Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Hypertension (Dallas, Tex. : 1979)|September 17, 2025
Blood Pressure and Mortality in Mexico City: A Mendelian Randomization StudyMichael Turner, Pablo Kuri-Morales, Jesús Alegre-Díaz, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 21, 2022
Diagnostic Accuracy of Capillary Blood Glucometer Testing for Gestational DiabetesHéctor Gallardo-Rincón, Julieta Lomelin-Gascon, Luis Alberto Martinez-Juarez, et al.
The Journal of Clinical Endocrinology and Metabolism|April 10, 2025
Prediabetes and risk of all-cause and cause-specific mortality: a prospective study of 114,062 adults in Mexico CityCarlos A Fermín-Martínez, Omar Yaxmehen Bello-Chavolla, César Daniel Paz-Cabrera, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Rare protein-coding variation and the genetic architecture of height in >1.4 million individualsJack A Kosmicki, Liron Ganel, Kyoko Watanabe, et al.
Science Advances|November 16, 2022
Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetesAbhishek Nag, Ryan S Dhindsa, Jonathan Mitchell, et al.
Scientific Reports|April 28, 2023
MIDO GDM: an innovative artificial intelligence-based prediction model for the development of gestational diabetes in Mexican womenHéctor Gallardo-Rincón, María Jesús Ríos-Blancas, Janinne Ortega-Montiel, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2024
Prediabetes as a risk factor for all-cause and cause-specific mortality: a prospective analysis of 115,919 adults without diabetes in Mexico CityCarlos A Fermín-Martínez, Omar Yaxmehen Bello-Chavolla, César Daniel Paz-Cabrera, et al.
Pathogens (Basel, Switzerland)|March 29, 2023
The Low Variability of Tc24 in Trypanosoma cruzi TcI as an Advantage for Chagas Disease Prophylaxis and Diagnosis in MexicoIngeborg Becker, Haydee Miranda-Ortiz, Edith A Fernández-Figueroa, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Pageof 13